Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Pre‐emptive pharmacogenetics (PGx) testing of a panel of germline genetic variants represents a new model for personalized medicine. Clinical impact of PGx testing is maximized when all variant alleles for which actionable clinical guidelines are available are included in the test panel. However, no...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wouden, Cathelijne H., van Rhenen, Mandy H., Jama, Wafa O.M., Ingelman‐Sundberg, Magnus, Lauschke, Volker M., Konta, Lidija, Schwab, Matthias, Swen, Jesse J., Guchelaar, Henk‐Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771671/
https://www.ncbi.nlm.nih.gov/pubmed/31038729
http://dx.doi.org/10.1002/cpt.1489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771671/
https://www.ncbi.nlm.nih.gov/pubmed/31038729
http://dx.doi.org/10.1002/cpt.1489

Ejemplares similares